Differential diagnosis of acute thrombocytopenia relies on a structured framework distinguishing pseudothrombocytopenia (artifact from in-vitro platelet clumping), decreased platelet production, and increased platelet destruction, with the latter further subdivided into immune-mediated (antibody-driven) and non-immune-mediated mechanisms; corroborating clues include peripheral smear findings (platelet size/reticulated platelet fraction as production markers, schistocytes suggesting microangiopathic hemolysis), the presence or absence of splenomegaly, and the trajectory and magnitude of platelet decline relative to a defined trigger. This encompasses immune thrombocytopenia (ITP) and its antibody-mediated destruction mechanism and treatment principles, heparin-induced thrombocytopenia (HIT) and its paradoxical pro-thrombotic pathophysiology with defined temporal and magnitude criteria (the "4T"-type reasoning) that distinguish it from more common causes of hospital-acquired thrombocytopenia (consumption from critical illness, tissue injury-triggered coagulation activation), and anemia-of-inflammation as a distinct entity from iron-deficiency anemia based on iron study patterns. This belongs to clinical hematology, integrating pathophysiologic reasoning about platelet kinetics and immune mechanisms with a systematic diagnostic approach.
Differential diagnosis of acute thrombocytopenia relies on a structured framework distinguishing pseudothrombocytopenia (artifact from in-vitro platelet clumping), decreased platelet production, and …